The Korean Journal of Gastroenterology :eISSN 2233-6869 / pISSN 1598-9992


Table. 2.

Thromboembolic Risk after Discontinuation of Anti-platelet Agents

Thrombotic risk SIHD ACS or CV risk factorsa) Management
High <1 mo <3 mo Defer procedure
Intermediate 1–6 mo 3–12 mo Defer procedure until the risk is low if possible
Low >6 mo >12 mo Perform procedure
Continue aspirin
Withhold P2Y12 receptor inhibitor 5–7 days before the high-risk procedure

ACS, acute coronary syndrome; CV, cardiovascular; SIHD, stable ischemic heart disease.

aRisk factors: previous myocardial infarctions, previous stent thrombosis, congestive heart failure (Left ventricular ejection fraction <35%), chronic kidney disease, diabetes mellitus.

Korean J Gastroenterol 2024;83:217~232
© Korean J Gastroenterol